SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000874015-20-000084
Filing Date
2020-06-29
Accepted
2020-06-29 21:47:59
Documents
1
Period of Report
2020-06-25

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 7014
  Complete submission text file 0000874015-20-000084.txt   8418
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Issuer) CIK: 0000874015 (see all company filings)

IRS No.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7 TECHNOLOGY DRIVE IRVINE CA 92618
Business Address
Castleman Breaux (Reporting) CIK: 0001335073 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19125 | Film No.: 201000134